Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1Phase 1/2 1

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3CNS 2Other 1

Conditions

Lymphoma 152Precursor Cell Lymphoblastic Leukemia-Lymphoma 93Lymphoma, Follicular 81Lymphoma, Large B-Cell, Diffuse 80Leukemia 79Lymphoma, Non-Hodgkin 75Hodgkin Disease 74Burkitt Lymphoma 67Leukemia, Lymphocytic, Chronic, B-Cell 63Lymphoma, Large-Cell, Immunoblastic 58Lymphoma, Mantle-Cell 53Lymphoma, B-Cell, Marginal Zone 52Myelodysplastic Syndromes 40Leukemia, Myeloid, Chronic-Phase 36Leukemia, Myeloid, Acute 36Dendritic Cell Sarcoma, Interdigitating 33Leukemia, Myeloid, Accelerated Phase 32Neoplasms, Plasma Cell 30Multiple Myeloma 30Recurrence 28Blast Crisis 23Myeloproliferative Disorders 22Congenital Abnormalities 21Leukemia, Myelomonocytic, Chronic 20Mycosis Fungoides 19Myelodysplastic-Myeloproliferative Diseases 17Lymphoma, Large-Cell, Anaplastic 17Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 17Graft vs Host Disease 17Waldenstrom Macroglobulinemia 16

Interventions

Vincristine 4Radiotherapy 3Procarbazine 3Methotrexate 3Cytarabine 3Rituximab 2Prednisolone 2Cyclophosphamide 2motexafin gadolinium 1glutamic acid diethyl ester 1glucarpidase 1fludarabine phosphate 1fludarabine 1axicabtagene ciloleucel 1Simvastatin 1Neuropsychological Tests 1Methylprednisolone 1Magnetic Resonance Spectroscopy 1Leucovorin 1Interleukin 1 Receptor Antagonist Protein 1Glutamine 1Glutamic Acid 1Etoposide 1Doxorubicin 1Dietary Supplements 1Dexamethasone 1Contrast Media 1Bendamustine Hydrochloride 1Baclofen 1AP 1903 reagent 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Neurotoxicity Syndromes × Radiotherapy × Lymphoid × Clear all
NCT00666484 2014-12-04

Combination Chemotherapy in Treating Younger Patients With Hodgkin Lymphoma

University College, London

Phase 2 Completed
47 enrolled
Lymphoid

Hodgkin Disease, Lymphoma, Neurotoxicity Syndromes

NCT00727831 2014-01-27

Methotrexate, Glucarpidase, and Leucovorin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma

University College, London

Phase 1/2 Completed
4 enrolled
LymphoidOther

Lymphoma, Lymphoma, Large B-Cell, Diffuse, Neurotoxicity Syndromes, Mucositis

NCT00734773 2012-05-18

Pilot Study of MGd + High-dose MTX-Based Chemoimmunotherapy + RT for Newly Dx PCNSL

Northwestern University

Phase EARLY_PHASE1 Withdrawn
CNSLymphoid

Lymphoma, Central Nervous System Neoplasms, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡